Founder, MindMed

JR is a former Silicon Valley tech executive & Founder of MindMed, the psychedelic medicine business he launched after realising that transformational solutions to mental illness and addiction might lie within psychedelics. He spent 2 years researching and began personally investing in psychedelic research through his investment company. JR partnered with drug development veteran Stephen Hurst to start MindMed in 2019, assembling a leading clinical drug discovery and development team with vast experience conducting clinical trials and research on drug candidates derived from psychedelics.